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Abstract
Background. The appropriate management of the pancreatic remnant following distal pancreatic resection remains a
clinically relevant problem. We carried out a retrospective analysis which focused on this issue and compared the two
favored techniques of suture and staple closure. Patients and methods. Forty-six patients underwent distal pancreatectomy
between October 1999 and January 2006. The patients were retrospectively analysed based on the management of the
remaining pancreatic gland. Thirty-seven patients had suture and nine patients had staple closure. The morbidity, mortality,
incidence of pancreatic fistula, necessity of secondary surgical intervention, and the duration of hospital stay for the two
groups were compared. Pancreatic fistula was considered according to the novel international standard definition (ISGPF).
In addition, subgroup analysis of patients receiving octreotide was carried out. Results. Overall, postoperative morbidity due
to pancreatic fistula occurred in seven patients (19%) after suture and in one patient (11%) after staple closure (p0.54),
with no deaths. The number of patients with surgical revision related to pancreatic leakage was two (5%) after suture closure
vs no revision after staple closure (p0.65). The median number of total hospital days for the suture group was 19 (range
778 days) vs 21 (range 1296 days) for the stapler group (p0.21). No significant benefit for the octreotide application
could be determined. Conclusion. According to the data, no significant difference for either suture or stapler closure was
observed, with the tendency for staple closure to be superior.
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Introduction
Distal pancreatectomy is a relevant procedure for
chronic pancreatitis, other benign diseases, malignant
diseases, cysts of the pancreas, and pancreatic par-
enchyma damage after abdominal trauma, with over-
all increasing frequency and decreasing mortality
below 5% in high volume centers [13]. Despite the
experience gained since the technique for distal
pancreas resection was outlined by Mayo in 1913
[4], the management of the remaining pancreatic
tissue is still a considerable clinical problem [5,6]. In
particular, pancreatic leak following distal pancreatic
resection has been the foremost complication in terms
of frequency and associated morbidity [79]. It is
believed that patients with a non-dilated Wirsung’s
duct and a soft friable pancreatic gland are especially
susceptible to this complication [1013].
From a very early stage, surgeons tried to minimize
the complication rate with suitable techniques includ-
ing end-to-side pancreaticojejunostomy [14]. Never-
theless, staple closure and suture closure of the
pancreatic remnant have been the standard techni-
ques referred to most [1,1517]. Several other
strategies, such as fibrin glue sealing of the stump or
anastomosis, sealing of the parenchyma of the pan-
creatic stump with a radiofrequency device, patching
the pancreatic stump with an omental plug or a patch
taken from the falciform ligament, and the use of an
ultrasonic or harmonic scalpel for tissue dissection,
have been advocated as successful [9,1821].
Furthermore, the development of techniques does
not stand still and a novel method covering the
pancreatic stump with the serosal surface of the first
jejunal loop has been introduced recently [22]. How-
ever, no technique has proven to be satisfactory for all
patients.
At the Department of General Surgery of the
University of Wu¨rzburg, the techniques of suture
and staple closure of the pancreatic remnant after
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distal pancreatic resection have been performed
exclusively. The aim of the present retrospective
analysis of patients was an attempt to provide addi-
tional data as to which technique may be superior in
terms of mortality, morbidity, and incidence of
pancreatic fistula.
Patients and methods
Patients
A retrospective analysis of 46 patients (18 men, 28
women) receiving open left-sided or distal pancrea-
tectomy between October 1999 and January 2006 was
carried out. The patients’ characteristics are summar-
ized in Table I. The patients were divided into two
groups according to the management of the pancrea-
tic remnant. Thirty-seven patients (14 men, 23
women) with an age range of 2879 years underwent
suture closure and 9 patients (4 men, 5 women) with
an age range of 1786 years had staple closure.
Surgical technique
All pancreatic resections were performed in accor-
dance with the standardized procedure described
elsewhere [23]. The common part of the distal
pancreatectomy includes the transection of the pan-
creas to the left of the hepatic portal vein/superior
mesenteric vein. At the Department of General
Surgery of the University of Wu¨rzburg, two techni-
ques of pancreatic stump closure after distal pancrea-
tectomy have been used in parallel. The attending
surgeons made the decision as to which technique was
preferred intraoperatively for each individual patient.
In the suture method, the Wirsung’s duct was first
identified and afterwards ligated with non-absorbable
sutures. After sewing the main pancreatic gland, the
cut surface of the pancreatic gland was closed with
interrupted, non-absorbable sutures that joined ven-
tral and dorsal edges of the gland according to the fish
mouth technique. In 20 patients (54%), the trans-
ected pancreatic gland was additionally sealed with
TachoComb, a biodegradable hemostyptic (Nycomed
Pharmaceutical Co. Ltd, Denmark). The intended
benefit of the topical fibrin sealant application was to
support sealing of the bleeding pancreatic surface. In
the stapler group, a linear stapler GIA 50 or 90 mm
(Tyco, Gosport, UK) was used in six patients and an
ILA 75 stapler (Tyco) in three patients. In this group,
the TachoComb hemostyptic was applied in four
cases (44%).
Overall, a concomitant splenectomy was carried out
in 26 patients (55%). All patients had at least an intra-
abdominal open drain (easy-flow) with their tips
placed on the pancreatic remnant.
Octreotide prophylaxis
Octreotide (Novartis Pharma, Nu¨rnberg, Germany)
is the octapeptide analog of somatostatin, which is a
powerful inhibitor of pancreatic secretion. Twenty-
nine patients (78%) with suture and five patients
(56%) with staple closure received octreotide (2100
or 3100 or 3200 mg/day s.c.) before surgery
(within 2 h of the start of surgery) and after surgery
for 8 days.
Perioperative management
The intra-abdominal easy-flow drains were removed
as soon as the amount of serosanguinous drainage
fluid wasB20 ml per 24 h. The diagnosis of pancrea-
tic fistula was suspected on the basis of conspicuous
macroscopic appearance of drain fluid that looked like
pancreatic juice. Concomitant clinical findings could
be inconstantly observed and ranged from abdominal
pain and impaired bowel function to fever (388C),
serum leukocyte count 10 000 cells/mm3, and in-
creased C-reactive protein. The pancreatic enzymes
amylase and lipase were initially measured in the easy-
flow drain fluid after suspicion of pancreatic fistula. In
the case of a pancreatic fistula, further management
depended on the individual patient; nevertheless,
negative pancreatic enzyme secretion in the drain
fluid was confirmed before removal of the drainage.
Definition of pancreatic fistula
In accordance with the novel international consensus
agreement [24], pancreatic fistula was defined as a
drainage fluid beyond the third postoperative day with
at least threefold elevation of normal serum amylase
(B110 IU/ml). The grading system (grades A, B, and
C) of severity of pancreatic fistula was applied after
complete follow-up (Table II).
Statistics
Statistical analysis for the data was done using the
Fisher’s exact or MannWhitney U test. Statistical
significance was taken as pB0.05.
Table I. Patient characteristics and indications for distal pancreatic
resection.
Parameter Suture closure Staple closure
Number of patients 37 9
Median age (years)9SD 54916 55926
Gender (male: female) 14: 23 4: 5
Indications
Pancreatic tumor 24 6
Chronic pancreatitis 7 1
Stomach tumor 4 0
Abdominal trauma 1 1
Others 1 1
Splenectomy 20 6
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Results
Indications for distal pancreatectomy were pancreatic
tumors in 30 patients, chronic pancreatitis in 8
patients, stomach tumors in 4 patients, abdominal
trauma in 2 patients, and other reasons in 2 additional
patients (Table I). In the suture group, operation was
done for malignancy in 9 of 37 cases (24%) and in 3
of 9 cases (33%) in the stapler group. Splenectomy
was additionally performed in 26 patients. Distal
pancreatectomy was extended in nine patients (gas-
trectomy or partial gastrectomy in four, partial colon
resection in four and partial hepatectomy in one).
A summary of postoperative data of patients is
presented in Table III. There was no hospital mortal-
ity in either the suture or the stapler group. Nineteen
patients (51%) in the suture group and five patients
(56%) in the stapler group had no postoperative
complications. Seven patients (19%) in the suture
group and one patient (11%) in the stapler group
developed a pancreatic fistula. The difference is not
statistically significant. The patients with pancreatic
fistula were subdivided according to the severity
grading system. In the suture group, prolonged
pancreatic drainage of 21 days combined with
partial signs of infection occurred in four patients
(severity grade B). Two of those required additional
CT-guided drainage of pancreatic leakage formation.
Re-operation due to pancreatic leakage was necessary
for two patients with suture closure of the pancreatic
remnant (severity grade C). One patient had no
serious sequel following pancreatic fistula and drai-
nage was suspended without further treatment (se-
verity grade A). In the stapler group, the one patient
with pancreatic fistula required CT-guided drainage
(severity grade B). No re-operation was performed.
Bowel dysfunction or delayed gastric emptying was
noted for seven patients (18%) in the suture group vs
no patients in the stapler group. The difference is not
statistically significant.
Overall, for the eight patients with postoperative
pancreatic fistula, the median (range) time to resolu-
tion of fistula was 29 (1368) days.
A subgroup analysis was carried out to exclude bias
towards sutured closure for extended or complicated
resections. Extended distal resection was performed
in the suture group in seven cases (19%) vs three cases
(33%) in the stapler group. Postoperative pancreatic
fistula occurred in two of those patients (28%) in the
suture group. No pancreatic fistula was evident for
patients with extended resection and staple closure. In
summary, the rate of pancreatic fistula for suture
closure and extended resection (28%) compared to
the rate for suture closure and simple resection (17%)
was not statistically different. Likewise, no statistical
difference could be determined in the stapler group.
Furthermore, there was no statistically significant
difference in the development of pancreatic fistula
between benign versus malignant resection. Pancrea-
tic fistula occurred in 5 of 34 (15%) patients in whom
resection was done for benign disease, and in 2 of 12
(17%) patients with malignant disease.
In addition, subset analysis was performed for
octreotide application (Table III). Overall, 33 patients
(70%) received octreotide treatment regardless of the
method of pancreatic stump closure. The incidence of
pancreatic fistula was similar in the octreotide group
(18%, 6/33) and the non-octreotide group (15%,
2/13).
The median length of hospital stay was 19 days
(range 778 days) for patients in the suture group,
compared to a median of 21 days (range 1296 days)
for the patients who underwent staple closure. The
difference between groups is not statistically signifi-
cant.
Discussion
The comparison of different studies with regard to
pancreatic fistula formation after distal pancreatect-
omy remains problematic due to the lack of a standard
definition of what constitutes a pancreatic fistula.
Specifically, more than 20 fistula definitions have
been reported [25]. As an attempt to solve the
problem, an international standard definition for
pancreatic fistula has recently been proposed [24].
Table II. Grading system of pancreatic fistula.
Grade A B C
Clinical conditions Well Often well Ill appearance/bad
Specific treatment* No Yes/no Yes
US/CT (if obtained) Negative Negative/positive Positive
Persistent drainage (after 3 weeks)$ No Usually yes Yes
Re-operation No No Yes
Death related to pancreatic fistula No No Possibly yes
Signs of infections No Yes Yes
Sepsis No No Yes
Re-admission No Yes/no Yes/no
US, ultrasonography; CT, computed tomographic scan.
*Partial (peripheral) or total parenteral nutrition, antibiotics, enteral nutrition, somatostatin analog, and/or minimal invasive drainage.
$With or without a drain in situ.
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In the present analysis, considerable attention has
been focused on the novel definition. Therefore, this
dataset will be more comparable to others and thus of
direct clinical value.
The safety of distal pancreas resection has increased
in recent years, mainly due to the improvement of the
mortality rates, withB5%, reported in high volume
centers [1,2]. This is in accordance with the non-
mortality rate reported in our retrospective analysis.
On the other hand, morbidity remains high and can
be up to 64% [17]. Fistula formation related to the
operative management of pancreatic remnant is the
most commonly occurring complication after distal
pancreatectomy and almost exclusively the cause of
the high morbidity. Furthermore, pancreatic fistula is
combined with numerous other complications, such
as abscess formation, sepsis, enteric dysfunction, and
hemorrhage, and influences healthcare expenditure
for the patient [26]. Besides other techniques, stapler
closure and suture closure of the pancreatic stump
after resection are the most favored surgical proce-
dures to avoid pancreatic fistula formation [5].
In the present study, occurrence of pancreatic
fistula (which was considered as drainage fluid beyond
the third postoperative day with at least threefold
elevation of amylase) was not significantly different for
stapler and suture closure, with 19% vs 11%, respec-
tively. Nevertheless, this result tends to favor the
stapler closure over hand-sewn closure, in agreement
with a meta-analysis published in 2005 [5]. This
assumption is supported by the fact that no patient
with staple closure has required further operative
intervention related to pancreatic leakage. Moreover,
bowel dysfunction was not noted after staple closure.
It is supposed that the staple method resulted in less
extravasation of pancreatic fluid from the cut surface
of the residual pancreatic surface compared with the
suture method [17].
A standard technique for preventing drainage of
juice from the pancreatic resection surface including
the ligation of Wirsung’s duct has been proposed for
suture closure [8]. In this series, the main pancreatic
duct was always ligated in the context of suture
closure. In addition, small branches on the transected
pancreatic surface were closed using the fish mouth
technique, since the branches tend to be critical as a
source of pancreatic leak [9,17]. Despite this techni-
que, a rate of occurrence of a pancreatic leak of 9.6%,
as reported recently [27], could not be observed in
this study.
However, besides the surgical technique the sur-
geon is also considered a relevant risk factor for fistula
formation [23]. In this regard, within the observation
period of this systematic analysis, several surgeons
carried out the procedures at the University Hospital
of Wurzburg and this might explain the inferior rate of
Table III. Postoperative analysis of patients with distal pancreatic resection.
Parameter Suture closure (n37) Staple closure (n9) p value
Death 0 0
Complications
None 19 (51%) 5 (56%) NS
Yes 18 (49%) 4 (44%)
Pancreatic fistula* 7 (19%) 1 (11%) NS
Grade A 1 (3%) 0 NS
Grade B 4 (11%) 1 (11%) NS
Grade C 2 (5%) 0 NS
Intra-abdominal abscess$ 0 0
Bowel dysfunction 7 0 NS
Pulmonary complication 0 0
Renal complication 0 0
Hepatic complication 0 0
Others% 4 3 NS
CT-guided drainage$ 2 (5%) 1 (11%) NS
Re-operation$ 2 (5%) 0 NS
Time to resolution of pancreatic fistula (days)
Range 1363
Median 29
Octreotide application
Yes/no 33/13
Pancreatic fistula 6 (18%)/2 (15%) NS
Duration of hospital stay (days)
Range 778 1296
Median 19 21 NS
NS, not significant.
*According to the international consensus agreement [24].
$With respect to pancreatic fistula.
%Not related to pancreatic resection.
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pancreatic fistula in the group with suture closure
compared with the rate in the quoted report. On the
other hand, the staple technique seems to be simpler
to apply and this might explain the inferior rate of
pancreatic fistula besides the fact that several surgeons
performed the procedures.
The concept of perioperative inhibition of exocrine
pancreatic secretion by i.v. application of octreotide
(somatostatin) to reduce the postoperative morbidity
after pancreatic resection was first introduced in 1979
[28]. Although some studies [29] have shown a
significant advantage, the role of perioperative and
postoperative octreotide in prevention of pancreatic
fistula formation remains unclear. In this study, no
remarkable effect of octreotide for the rate of pan-
creatic fistula could be observed after subset analysis
of patients in the suture and the stapler groups.
According to the data, no significant benefit could
be shown for the suture group or the stapler group for
the duration of hospital stay. The most frequent
surgical complications were gastric emptying delay
and postoperative pancreatic fistula. In this series,
those complications were recorded in approximately
33% of the patients. Gastric emptying delay and
pancreatic fistula have clinical relevance, as the
affected patients remained in the hospital for more
than a week longer [30]. That fact, besides comorbid-
ities in some individuals, may explain the rather long
median length of hospital stay in the suture and
stapler groups. However, the length of hospital stay
is of inferior quality among clinical parameters when
discussing the impact of pancreatic fistula [24].
Finally, no significant difference could be shown for
either suture or stapler closure of the pancreatic
remnant after distal pancreatectomy. The suggested
advantage for staple closure needs to be interpreted
cautiously with respect to the number of evaluated
patients. The second conclusion is that further
clarification of the role of suture and stapler closure
is still required through large, high quality, rando-
mized trials, since the differences between stapler and
suture closure are rather small and unlikely to be
detected in single series. It is tempting to speculate
that the perfection of a technique in each individual
institution is just as important as the actual technique
applied.
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